A phase II, multi-center study of the EZH2 inhibitor, tazemetostat, in adult subjects with INI1-negative tumors including renal medullary carcinoma (RMC), or relapsed/refractory synovial sarcoma Meeting Abstract
| Authors: | Tannir, N. M.; Pressey, J.; Roche, M.; Rodstrom, J.; Blakemore, S.; Clawson, A.; Daigle, S.; Gounder, M. |
| Abstract Title: | A phase II, multi-center study of the EZH2 inhibitor, tazemetostat, in adult subjects with INI1-negative tumors including renal medullary carcinoma (RMC), or relapsed/refractory synovial sarcoma |
| Meeting Title: | 15th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 118 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Nov 4-5 |
| Meeting Location: | Miami, FL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-12-01 |
| Start Page: | 14 |
| Language: | English |
| ACCESSION: | WOS:000388478200021 |
| PROVIDER: | wos |
| PUBMED: | 27860174 |
| DOI: | 10.1111/bju.13694 |
| Notes: | Meeting Abstract -- Source: Wos |
